August 25, 2025FinancialTerumo to acquire OrganOx Limited, a leading innovator in organ preservation devices, marking strategic entry into the organ transplantation-related sector (PDF 186.45 KB) - Expanding opportunities for organ transplantation worldwide and contributing to the advancement of transplant medicine -
August 04, 2025FinancialNotice Concerning Completion of Disposal of Treasury Shares as Restricted Stock Remuneration (PDF 111.15 KB)
August 04, 2025FinancialNotice Concerning the Determination of Details of Issuance of Stock Options (Share Warrants) (PDF 109.66 KB)
The Latest Materials 1st Quarter Financial Results for FYE 3/2026 August 07, 2025 Financial Statements IFRS Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2026 (PDF 493.3 KB) Presentation Material Financial Results for the First Quarter of Fiscal Year Ending March 31, 2026 (FY2025) (PDF 861.05 KB) Financial Results for the First Quarter of Fiscal Year Ending March 31, 2026 (FY2025)(with note) (PDF 263.06 KB) Additional Information Revenue by Segment (PDF 386.94 KB) Revenue by Segment (Excel 124.21 KB) Q&A Q&A Session at the Financial Results Briefing for the First Quarter of Fiscal Year Ending March 31, 2026 (PDF 187.46 KB) Webcast Listen to the Webcast Financial Statements /investors/library/financial-statements Presentations /investors/library/presentations Terumo Report /investors/library/annual-reports Sustainability /sustainability Corporate Governance /about/governance Consolidated Financial Statements /investors/library/financial Adobe Reader is required for viewing PDF files. Download Adobe Reader
Financial Results for the First Quarter of Fiscal Year Ending March 31, 2026 (FY2025) (PDF 861.05 KB)
Financial Results for the First Quarter of Fiscal Year Ending March 31, 2026 (FY2025)(with note) (PDF 263.06 KB)
Q&A Session at the Financial Results Briefing for the First Quarter of Fiscal Year Ending March 31, 2026 (PDF 187.46 KB)